Treatment of Oral Hemangioma with 3% Sodium Tetradecyl Sulfate: Study of 20 Cases

15Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Hemangiomas possess an extremely challenging treatment dilemma for surgeons and the patients. Most of the hemangiomas involute but if they don't involutes or impair the vital functions or occur in adults they need intervention. Present study was conducted to evaluate and discuss the response of sclerosing agent 3% sodium tetradecyl sulfate (STDS) in oral hemangioma. All 20 cases of hemangioma were diagnosed clinically and were treated with 3% sodium tetradecyl sulfate (STDS) injections locally at regular intervals depending upon the size of the lesion. Hemangioma regressed in all the cases with considerable relief of symptoms with minimal complications. When used in appropriate doses, Sclerosing agent, 3% sodium tetradecyl sulfate (STD), is very effective for treatment of oral hemangioma. © 2011 Association of Otolaryngologists of India.

Cite

CITATION STYLE

APA

Agarwal, S. (2012). Treatment of Oral Hemangioma with 3% Sodium Tetradecyl Sulfate: Study of 20 Cases. Indian Journal of Otolaryngology and Head and Neck Surgery, 64(3), 205–207. https://doi.org/10.1007/s12070-011-0249-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free